Clinical Trial Update: Effect of Boceprevir on HCV-specific T Cell Responses

View source ↗

Summary

This completed clinical trial evaluated the effect of Boceprevir on HCV-specific T cell responses in chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Parma | Conditions: Chronic Hepatitis C | Status: COMPLETED